Pasmans, HellaHoes, JoskeTymchenko, Lizade Melker, Hester Evan der Klis, Fiona R M2020-09-272020-09-272020-08-201538-77553285661210.1158/1055-9965.EPI-20-0596http://hdl.handle.net/10029/624373Serum samples of men and women were used from two cross-sectional population-based serosurveillance studies performed before (2006-07, n = 6,384) and after (2016-17, n = 5,645) implementation of HPV vaccination in the Netherlands. Seven high-risk HPV-specific antibodies (HPV16, 18, 31, 33, 45, 52, and 58) were tested in a virus-like particle-based multiplex immunoassay.eninfo:eu-repo/semantics/closedAccessArticleCancer Epidemiol Biomarkers Prev 2020; 29(11):2243-54